Large pharmaceutical firm Novartis confirmed that it is halting and investigating several clinical trial programs involving ...
Eli Lilly will acquire Merida Biosciences for up to $2.875 billion, gaining MER511, a Phase I therapy targeting ...
The organization is nurturing talent alongside NIBRT to fill the region’s many life science manufacturing jobs.
Human-in-the-loop models could provide a credible and scalable path forward for using agentic AI in biopharma commercial ...
Genentech will invest $750 million in a fill-finish facility in Oregon, reached a construction milestone in North Carolina, ...
Argentine biotech firm Biosidus tripled its cell culture capacity with a $12.9 million expansion to boost biosimilar ...
Learn how strategic CHO cell line development accelerates biologics timelines and supports clinical progression with flexible ...
Large-scale validation of regenerative medicine, especially based on cell therapies, may come from cell therapies developed ...
Earlier this week, it was confirmed that a $380 million partnership between Bristol Myers Squibb (BMS) and contract ...
An expert from CTMC told BioProcess International how recent projects in Houston speak to the city’s drive to become a ...
Bristol Myers Squibb subsidiary RayzeBio has committed to building a radiopharmaceutical manufacturing facility in Whitestown ...
Industry expert Charley Maxwell shares essential strategies for biotech companies navigating Europe's fragmented regulatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results